000 01423 a2200301 4500
005 20250518042059.0
264 0 _c20200525
008 202005s 0 0 eng d
022 _a1434-4726
024 7 _a10.1007/s00405-019-05485-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSuton, Petar
245 0 0 _aIn reply to Swain et al.: Re-evaluation of updated meta-analysis including trials RTOG 1016 and De-ESCALaTE.
_h[electronic resource]
260 _bEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
_c07 2019
300 _a2113-2114 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aCetuximab
650 0 4 _aChemoradiotherapy
650 0 4 _aCisplatin
650 0 4 _aHumans
650 0 4 _aOropharyngeal Neoplasms
700 1 _aSkelin, Marko
700 1 _aRakusic, Zoran
700 1 _aDokuzovic, Stjepan
700 1 _aLuksic, Ivica
773 0 _tEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
_gvol. 276
_gno. 7
_gp. 2113-2114
856 4 0 _uhttps://doi.org/10.1007/s00405-019-05485-7
_zAvailable from publisher's website
999 _c29735103
_d29735103